The CYP4F22 gene helps make specialized skin fats that seal and protect the outer skin barrier. When both copies of this gene do not work properly, the barrier is weaker, so skin loses moisture more easily and can become very dry, thick, and scaly. This gene plays an important role in helping your skin stay flexible and shielded from everyday irritation. Variants in the CYP4F22 gene are linked to some inherited forms of ichthyosis, a condition that affects how the skin forms and sheds.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or manage activities across the body. Some genes carry the directions for producing proteins, which do much of the work inside cells. Other genes mainly regulate when processes happen, where they take place, and how active they are. Together, genes affect how the body grows and functions, and they can also influence how you respond to food, stress, and medications. More detailed information is available in the LearnHub.
Overview
CYP4F22Gene function
What if the gene works
The CYP4F22 gene helps skin cells make special fats needed for the outer skin barrier. This barrier reduces water loss and helps protect the body from irritants and germs.
Risk
What if the gene does not work
Variants in the CYP4F22 gene can cause a form of inherited ichthyosis, often with dry, thick, scaly skin from birth. Milder and more severe variants can affect how early changes appear and how extensive the scaling and redness become.
Treatment
What does that mean for your treatment
No treatment or drug selection approach specific to pathogenic variants in the CYP4F22 gene is currently established. Care is based on standard symptom guided ichthyosis treatment, such as regular skin moisturizers and, in some people, retinoids, rather than the CYP4F22 gene itself.
Conditions associated with CYP4F22
Gene function
What if the gene works
In your skin, the CYP4F22 gene helps build the oily layer that keeps the surface sealed and comfortable. Its protein is most active in the outer skin, where cells are turning into a strong barrier. This helps explain how the CYP4F22 gene supports the skin barrier and normal moisture balance.
Inside outer skin cells, the CYP4F22 gene helps make special fats called acylceramides (barrier lipids). These fats fill the spaces between skin cells and create part of normal skin barrier function.
Its protein changes very long fatty molecules so they can become skin sealing lipids. This supports the outermost skin layer as it forms a tight, flexible seal.
When the CYP4F22 gene works properly, skin can hold moisture more effectively. That steady barrier helps limit everyday water loss during washing, dry weather, and other routine exposures.
What is a variant?
A genetic variant is a small alteration in the DNA sequence of a gene. These changes are common and help create normal differences among people, such as appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. Sometimes, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CYP4F22 gene can make the enzyme unstable, change its shape, or stop cells from producing a full working version, so less of the lipid needed for a strong skin barrier is made. In practical terms, how CYP4F22 gene variants affect the skin barrier ranges from partial loss of function to near complete loss. Changes that leave some activity may be milder, while more disruptive variants can be linked to earlier or more marked ichthyosis.
How variants are linked to conditions
Pathogenic variants in the CYP4F22 gene cause autosomal recessive congenital ichthyosis, a group of inherited skin conditions present from birth. Many people have dry, tight skin with widespread scaling, and some are born covered by a shiny membrane that sheds in the first days of life. CYP4F22 gene variants linked to autosomal recessive congenital ichthyosis are often associated with lamellar ichthyosis or a closely related form of ichthyosis.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply contribute to natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one well understood variant in a particular gene is enough to establish the diagnosis.
Are there things that can increase or change my risk?
For CYP4F22, risk is mainly shaped by inheritance rather than lifestyle. A child is most likely to be affected when both parents carry a harmful CYP4F22 change and the child inherits two changed copies; family history and related-parent pregnancies can raise that chance. There is not enough evidence to say that diet, exercise, or other daily habits change this genetic risk.
Inheritance of CYP4F22 variants
CYP4F22-related skin conditions are inherited in an autosomal recessive pattern. This means a child usually needs to inherit two CYP4F22 gene variants, one from each parent, to be affected, while parents with one variant are typically healthy carriers. In practical terms, when both parents carry a CYP4F22 gene variant, each pregnancy has a 25% chance of an affected child, a 50% chance of a carrier child, and a 25% chance of a child with neither variant.
What does my CYP4F22 result mean for my family?
For CYP4F22, family implications are usually those of a recessive skin condition present from birth. Brothers and sisters may also be affected or may carry the same gene change without having symptoms, and parents are often healthy carriers. Other close relatives may also be carriers, so family testing may be worth discussing.
Genetic information
Genetic testing
How you find out about variants
CYP4F22 genetic testing looks for variants in the CYP4F22 gene, usually from a blood sample or cheek swab, to help clarify inherited ichthyosis. A lab reads the gene's DNA code and compares it with the usual sequence to identify changes that may explain a person's skin condition.
When should I consider getting a genetic test?
Consider testing the CYP4F22 gene if a baby is born with tight, shiny skin or later develops lifelong thick, dry, scaly skin, especially when similar skin changes run in the family. Testing can help confirm a rare inherited skin condition and clarify the chance of it affecting future children.
A genetic result is only one part of your health story
Genetic test results can provide valuable insight, but what they can tell you varies with the condition and the kind of variant found. How your body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and is most useful when considered with other parts of care. In other situations, a genetic finding may give a clear answer. For topics like response to medications, genetic results can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same medication may work well for one person but less well for another, or why some people are more sensitive to side effects. These differences are common and are one of several reasons treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics looks at how differences in a person’s genes can shape their response to medications. It examines the relationship between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes affect either how strongly a drug works or how the body processes it. This information can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the CYP4F22 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so any questions about side effects, new symptoms, or changes to treatment are best discussed with your doctor.
History
The CYP4F22 gene entered the medical literature through research on inherited forms of congenital ichthyosis, a group of skin conditions recognized long before their genetic causes were known. In the mid 2000s, researchers linked CYP4F22 variants to autosomal recessive congenital ichthyosis, helping clarify why some families had similar skin findings across generations. This discovery added CYP4F22 to a growing list of genes involved in the skin barrier and marked an important step in sorting different ichthyosis types by cause rather than appearance alone. From these first observations, research expanded steadily. Later studies refined the range of CYP4F22 variants and confirmed its place in genetic testing panels used for inherited skin conditions.